Alternatives
Alternatives to Sunlenca 300 mg tablet
1 other presentations of Lenacapavir 300 mg tablet
There are 1 alternatives to this medicine in the catalogue: the same active ingredient (Lenacapavir), strength (300 mg) and dosage form (tablet) from 1 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Sunlenca 300 mg tabletThis pageOral | Gilead Sciences | US FDA | 1 pouch, 1 pouch | Store bottle and blister packs at 20 °C – 25 °C (68 °F – 77 °F), excursions permitted to 15 °C – 30 °C (59 °F – 86 °F). Store at 20 °C to 25 °C (68 °F to 77 °F), excursions permitted between 15 °C to 30 °C (59 °F to 86 °F). Dispense and store only in original bottle or blister pack. | On request | — | Available on request |
| Yeztugo 300 mg tabletOral | Gilead Sciences | US FDA | 4 tablets | Store bottle at 20 °C – 25 °C (68 °F – 77 °F), excursions permitted to 15 °C – 30 °C (59 °F – 86 °F). Store at 20 °C – 25 °C (68 °F – 77 °F), excursions permitted to 15 °C – 30 °C (59 °F – 86 °F). Dispense and store only in original container. Keep the vials in the original carton until just prior to preparation of the injections in order to protect from light. | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Sunlenca 300 mg tabletNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.